CD70 and cancer: Notably, except in haematopoietic and lymphoid malignancies, CD70 genetic alterations were extremely rare in cancers, as mutations and/or CNV loss were observed in less than 1.5% of 35 993 tumour samples included in the COSMIC database (Tables S5a and S5b).